Besides, Securities and Exchange Board of India (Sebi) has also dealt with cases related to delisting of Astrazeneca Pharma and Cable Corporation of India.
"Sebi has informed that it has received seven complaints against companies which have started the process of delisting," Minister of State for Finance Jayant Sinha said in a written reply to the Lok Sabha.
"Appropriate actions wherever applicable have been initiated by Sebi," it added.
Sinha also said that following concerns from various stakeholders including stock exchanges, market participants and industry representatives, the Sebi Board last month had approved certain proposals to make delisting process more effective.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
